adi pharma limited
adi pharma limited Company Information
Company Number
09897158
Website
adipharma.co.ukRegistered Address
unit 4 the workshops, greenfield road, bedford, MK45 5BF
Industry
Retail sale via mail order houses or via Internet
Wholesale of pharmaceutical goods
Telephone
01525837370
Next Accounts Due
August 2024
Group Structure
View All
Directors
Urvashiben Kapadiya8 Years
Shareholders
urvashiben kapadiya 100%
adi pharma limited Estimated Valuation
Pomanda estimates the enterprise value of ADI PHARMA LIMITED at £2.9m based on a Turnover of £6.3m and 0.46x industry multiple (adjusted for size and gross margin).
adi pharma limited Estimated Valuation
Pomanda estimates the enterprise value of ADI PHARMA LIMITED at £1.2m based on an EBITDA of £264.5k and a 4.7x industry multiple (adjusted for size and gross margin).
adi pharma limited Estimated Valuation
Pomanda estimates the enterprise value of ADI PHARMA LIMITED at £2.4m based on Net Assets of £1.2m and 2.04x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Adi Pharma Limited AI Business Plan
In just minutes, we combine Pomanda’s company and industry data with cutting edge Artificial Intelligence to build a comprehensive 27 section business plan. You then have 60 days to tailor the information, decide which sections to include or exclude, and add your own branding logos, images and color scheme to create your perfect plan.
Adi Pharma Limited Overview
Adi Pharma Limited is a live company located in bedford, MK45 5BF with a Companies House number of 09897158. It operates in the wholesale of pharmaceutical goods sector, SIC Code 46460. Founded in December 2015, it's largest shareholder is urvashiben kapadiya with a 100% stake. Adi Pharma Limited is a young, mid sized company, Pomanda has estimated its turnover at £6.3m with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Adi Pharma Limited Health Check
Pomanda's financial health check has awarded Adi Pharma Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 4 areas for improvement. Company Health Check FAQs
5 Strong
3 Regular
4 Weak
Size
annual sales of £6.3m, make it smaller than the average company (£13.2m)
- Adi Pharma Limited
£13.2m - Industry AVG
Growth
3 year (CAGR) sales growth of -1%, show it is growing at a slower rate (6.5%)
- Adi Pharma Limited
6.5% - Industry AVG
Production
with a gross margin of 29.6%, this company has a comparable cost of product (29.6%)
- Adi Pharma Limited
29.6% - Industry AVG
Profitability
an operating margin of 4.2% make it as profitable than the average company (3.9%)
- Adi Pharma Limited
3.9% - Industry AVG
Employees
with 3 employees, this is below the industry average (22)
3 - Adi Pharma Limited
22 - Industry AVG
Pay Structure
on an average salary of £46.4k, the company has an equivalent pay structure (£46.4k)
- Adi Pharma Limited
£46.4k - Industry AVG
Efficiency
resulting in sales per employee of £2.1m, this is more efficient (£396.2k)
- Adi Pharma Limited
£396.2k - Industry AVG
Debtor Days
it gets paid by customers after 86 days, this is later than average (42 days)
- Adi Pharma Limited
42 days - Industry AVG
Creditor Days
its suppliers are paid after 69 days, this is slower than average (35 days)
- Adi Pharma Limited
35 days - Industry AVG
Stock Days
it holds stock equivalent to 3 days, this is less than average (69 days)
- Adi Pharma Limited
69 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 34 weeks, this is more cash available to meet short term requirements (16 weeks)
34 weeks - Adi Pharma Limited
16 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 57.6%, this is a lower level of debt than the average (65.6%)
57.6% - Adi Pharma Limited
65.6% - Industry AVG
adi pharma limited Credit Report and Business Information
Adi Pharma Limited Competitor Analysis
Perform a competitor analysis for adi pharma limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.
adi pharma limited Ownership
ADI PHARMA LIMITED group structure
Adi Pharma Limited has no subsidiary companies.
Ultimate parent company
ADI PHARMA LIMITED
09897158
adi pharma limited directors
Adi Pharma Limited currently has 1 director, Mrs Urvashiben Kapadiya serving since Dec 2015.
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mrs Urvashiben Kapadiya | England | 35 years | Dec 2015 | - | Director |
ADI PHARMA LIMITED financials
Adi Pharma Limited's latest turnover from November 2022 is estimated at £6.3 million and the company has net assets of £1.2 million. According to their latest financial statements, Adi Pharma Limited has 3 employees and maintains cash reserves of £1 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Nov 2022 | Nov 2021 | Nov 2020 | Nov 2019 | Nov 2018 | Nov 2017 | Nov 2016 | |
|---|---|---|---|---|---|---|---|
| Turnover | |||||||
| Other Income Or Grants | |||||||
| Cost Of Sales | |||||||
| Gross Profit | |||||||
| Admin Expenses | |||||||
| Operating Profit | |||||||
| Interest Payable | |||||||
| Interest Receivable | |||||||
| Pre-Tax Profit | |||||||
| Tax | |||||||
| Profit After Tax | |||||||
| Dividends Paid | |||||||
| Retained Profit | |||||||
| Employee Costs | |||||||
| Number Of Employees | 3 | 3 | 3 | 2 | |||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Nov 2022 | Nov 2021 | Nov 2020 | Nov 2019 | Nov 2018 | Nov 2017 | Nov 2016 | |
|---|---|---|---|---|---|---|---|
| Tangible Assets | 155,698 | 155,808 | 729 | 911 | 1,139 | 1,423 | 279 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 155,698 | 155,808 | 729 | 911 | 1,139 | 1,423 | 279 |
| Stock & work in progress | 39,754 | 42,000 | 22,000 | 0 | 0 | 0 | 0 |
| Trade Debtors | 1,501,351 | 1,228,398 | 1,197,084 | 1,251,258 | 960,481 | 444,497 | 208,981 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 0 | 2,890 | 2,890 | 0 | 0 | 0 | 0 |
| Cash | 1,034,029 | 655,540 | 540,739 | 0 | 0 | 0 | 0 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 2,575,134 | 1,928,828 | 1,762,713 | 1,251,258 | 960,481 | 444,497 | 208,981 |
| total assets | 2,730,832 | 2,084,636 | 1,763,442 | 1,252,169 | 961,620 | 445,920 | 209,260 |
| Bank overdraft | 400,516 | 147,293 | 754 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 851,656 | 623,169 | 629,013 | 719,958 | 611,906 | 360,804 | 205,501 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 320,423 | 370,692 | 387,772 | 0 | 0 | 0 | 0 |
| total current liabilities | 1,572,595 | 1,141,154 | 1,017,539 | 719,958 | 611,906 | 360,804 | 205,501 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 1,520 | 1,520 | 770 | 667 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 0 | 1,520 | 1,520 | 770 | 667 |
| total liabilities | 1,572,595 | 1,141,154 | 1,017,539 | 721,478 | 613,426 | 361,574 | 206,168 |
| net assets | 1,158,237 | 943,482 | 745,903 | 530,691 | 348,194 | 84,346 | 3,092 |
| total shareholders funds | 1,158,237 | 943,482 | 745,903 | 530,691 | 348,194 | 84,346 | 3,092 |
| Nov 2022 | Nov 2021 | Nov 2020 | Nov 2019 | Nov 2018 | Nov 2017 | Nov 2016 | |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Operating Profit | |||||||
| Depreciation | 110 | 182 | |||||
| Amortisation | 0 | 0 | |||||
| Tax | |||||||
| Stock | -2,246 | 20,000 | 22,000 | 0 | 0 | 0 | 0 |
| Debtors | 270,063 | 31,314 | -51,284 | 290,777 | 515,984 | 235,516 | 208,981 |
| Creditors | 228,487 | -5,844 | -90,945 | 108,052 | 251,102 | 155,303 | 205,501 |
| Accruals and Deferred Income | -50,269 | -17,080 | 386,252 | 0 | 750 | 103 | 667 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | |||||||
| Investing Activities | |||||||
| capital expenditure | |||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | |||||||
| Financing Activities | |||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | |||||||
| interest | |||||||
| cash flow from financing | |||||||
| cash and cash equivalents | |||||||
| cash | 378,489 | 114,801 | 540,739 | 0 | 0 | 0 | 0 |
| overdraft | 253,223 | 146,539 | 754 | 0 | 0 | 0 | 0 |
| change in cash | 125,266 | -31,738 | 539,985 | 0 | 0 | 0 | 0 |
P&L
November 2022turnover
6.3m
+21%
operating profit
264.4k
0%
gross margin
29.7%
-3.12%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
November 2022net assets
1.2m
+0.23%
total assets
2.7m
+0.31%
cash
1m
+0.58%
net assets
Total assets minus all liabilities
Similar Companies
adi pharma limited company details
company number
09897158
Type
Private limited with Share Capital
industry
47910 - Retail sale via mail order houses or via Internet
46460 - Wholesale of pharmaceutical goods
incorporation date
December 2015
age
9
accounts
Total Exemption Full
ultimate parent company
previous names
N/A
incorporated
UK
address
unit 4 the workshops, greenfield road, bedford, MK45 5BF
last accounts submitted
November 2022
adi pharma limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 3 charges/mortgages relating to adi pharma limited. Currently there are 3 open charges and 0 have been satisfied in the past.
adi pharma limited Companies House Filings - See Documents
| date | description | view/download |
|---|
